TScan Therapeutics, Inc. says two top leaders are leaving, and new ones are being chosen.

Sep 30, 2026, 5:08 PM ETNew bossRead the original at SEC EDGAR

Neutral

TScan confirmed planned exits by its finance and medical chiefs. Pay continues, and cash awards depend on a company milestone, but the filing reports no change to its research or drug programs.

TCRX · TScan Therapeutics, Inc.

AI read · Neutral

The AI's read

The filing confirms the planned exits of TScan's finance and medical chiefs. Their pay and benefits continue, and each could receive a cash award if a company milestone is met before leaving. Those costs matter, but the filing does not report a change to TScan's research or drug programs.

Get alerts for TCRX

Follow TScan Therapeutics, Inc. (TCRX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TCRX

Free on the App Store and Google Play, or on the web.